Maravai LifeSciences Announces Investor Conference Schedule for the Month of May 2021
May 05 2021 - 4:10PM
Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of
life science reagents and services to researchers and biotech
innovators, is scheduled to participate in the following virtual
investor conferences during the month of May.
On May 12, 2021, Kevin Herde, Chief Financial Officer, will
participate in a fireside chat at the Bank of America Global
Healthcare Conference at 10:15 a.m. PT.
On May 25, 2021, Carl Hull, Chief Executive Officer will
participate in a fireside chat at the UBS Global Healthcare
Conference at 2:00 p.m. PT.
A live webcast of the presentations will be available to all
interested parties on the Maravai Lifesciences investor relations
website at http://investors.maravai.com. An archived version
of the webcast will be available a few hours following the
completion of each event on the Maravai investor relations
website.
About Maravai Maravai is a leading life
sciences company providing critical products to enable the
development of drug therapies, diagnostics, novel vaccines and
support research on human diseases. Maravai’s companies are leaders
in providing products and services in the fields of nucleic acid
synthesis, bioprocess impurity detection and analysis, and protein
labeling and detection to many of the world's leading
biopharmaceutical, vaccine, diagnostics, and cell and gene therapy
companies.
For more information about Maravai LifeSciences, visit
www.maravai.com.
Contact Information:
Media Contact: Sara Michelmore
MacDougall
+1 781-235-3060
maravai@macbiocom.com
Investor Contact: Deb Hart
Maravai LifeSciences
+ 1 858-988-5917
ir@maravai.com
Maravai LifeSciences (NASDAQ:MRVI)
Historical Stock Chart
From Aug 2024 to Sep 2024
Maravai LifeSciences (NASDAQ:MRVI)
Historical Stock Chart
From Sep 2023 to Sep 2024